Group items tagged

Peyronie's disease (Pdy) is a sexually transmitted disease caused by the infectious agent of the same name - the bacteria known as folliculitis. Peyronie's disease is more common in men than in women, with approximately 3% of men being affected by it. This disease is most commonly associated with poor oral hygiene, although sexual intercourse can also cause it. The precise causes of this condition are not known, but heredity, diabetes, and injury to the urethra may all be contributing factors. The primary treatment of Peyronies is the surgical removal of the papillae, which are found on the tip of the penis. Peyronie's disease (Pdy) is clinically classified as an intervertebral disk disease and is often difficult to diagnose. The growing prevalence of Peyronie's disease around the globe is propelling the growth of the Peyronie's disease treatment market. According to the American Academy of Family Physicians, it primarily affects men between 45 and 60 years of age, although an age range of 18 to 80 years. This disease occurs more often in men between 40 to 70 years older. Improved healthcare facilities across developing regions coupled with the availability of the multiple treatment options due to advancement in technology are again propelling the market growth. Moreover, the increasing geriatric population around the globe is further projected to foster the growth of Peyronie's disease treatment market. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/increasing-incidence-of-sexually.html